➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

CORTROSYN Drug Profile

Email this page to a colleague

« Back to Dashboard

Which patents cover Cortrosyn, and when can generic versions of Cortrosyn launch?

Cortrosyn is a drug marketed by Amphastar Pharms Inc and is included in one NDA.

The generic ingredient in CORTROSYN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cortrosyn

A generic version of CORTROSYN was approved as cosyntropin by MYLAN INSTITUTIONAL on December 17th, 2009.

  Get Started Free

Summary for CORTROSYN
Drug patent expirations by year for CORTROSYN
Drug Prices for CORTROSYN

See drug prices for CORTROSYN

Recent Clinical Trials for CORTROSYN

Identify potential brand extensions & 505(b)(2) entrants

Vanderbilt UniversityN/A
National Heart, Lung, and Blood Institute (NHLBI)N/A
National Institutes of Health (NIH)N/A

See all CORTROSYN clinical trials

Pharmacology for CORTROSYN

US Patents and Regulatory Information for CORTROSYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc CORTROSYN cosyntropin INJECTABLE;INJECTION 016750-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.